Immune remodulation in pediatric inherited metabolic liver diseases

doi:10.4254/wjh.v16.i9.1258

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1094)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

647

Figures (1-2)

Tables (1-1)

Sum=813

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=171

Publishing Process of This Article

Item

Count

Browse

Download

Sum=86

Sep 27, 2024 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 27, 2024; 16(9): 1258-1268
Published online Sep 27, 2024. doi: 10.4254/wjh.v16.i9.1258

Open in New Tab Full Size Figure Download Figure

Figure 1 Immune remodulation in pediatric inherited metabolic liver diseases. GSD1b: Glycogen storage disease type 1b; ROS: Reactive oxygen species; RNS: Reactive nitrogen specie; LT: Liver transplantation; MMA: Methylmalonic acidemia.

Open in New Tab Full Size Figure Download Figure

Figure 2 Mechanism of nitisinone in treating tyrosinemia. 4-HPP: 4-hydroxyphenylpyruvic acid.

Citation: Wu YC, Xiang XL, Yong JK, Li M, Li LM, Lv ZC, Zhou Y, Sun XC, Zhang ZJ, Tong H, He XY, Xia Q, Feng H. Immune remodulation in pediatric inherited metabolic liver diseases. World J Hepatol 2024; 16(9): 1258-1268
URL: https://www.wjgnet.com/1948-5182/full/v16/i9/1258.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i9.1258